{"entity":{"type":"insider","cik":"0001721442","url":"/insider/0001721442","json_url":"/insider/0001721442.json","name":"Sabag Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2018-02-20","last":"2026-05-04","span_basis":"filed_date"},"name_variants":[{"name":"Sabag Mark","source":"filing","n_filings":9,"first_seen":"2018-02-20","last_seen":"2026-05-04"}],"transactions":[{"id":5849990,"accession":"0001193125-26-203928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-203928","line_url":"/filing/0001193125-26-203928#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (See \"Remarks\")","role_mark":"O","role_mark_label":"Officer (See \"Remarks\")","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See \"Remarks\"","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144180.0,"shares_display":"144,180","price_per_share":34.9918,"price_display":"34.99","price_state":"stated","total_value":5045117.724,"total_display":"5,045,117.72","total_whole":"5,045,118","shares_owned_after":80760.0,"shares_owned_after_display":"80,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-04","scope":"insider"},{"id":5943763,"accession":"0001193125-26-115929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-115929","line_url":"/filing/0001193125-26-115929#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (See \"Remarks\")","role_mark":"O","role_mark_label":"Officer (See \"Remarks\")","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See \"Remarks\"","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62102.0,"shares_display":"62,102","price_per_share":30.141,"price_display":"30.14","price_state":"stated","total_value":1871816.382,"total_display":"1,871,816.38","total_whole":"1,871,816","shares_owned_after":224940.0,"shares_owned_after_display":"224,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-19","scope":"insider"},{"id":4202499,"accession":"0001193125-25-315923","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-315923","line_url":"/filing/0001193125-25-315923","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (See \"Remarks\")","role_mark":"O","role_mark_label":"Officer (See \"Remarks\")","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See \"Remarks\"","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":216892.0,"shares_display":"216,892","price_per_share":28.727451398852885,"price_display":"28.73","price_state":"stated","total_value":6230754.3888,"total_display":"6,230,754.39","total_whole":"6,230,754","shares_owned_after":150996.0,"shares_owned_after_display":"150,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-09","filed_date":"2025-12-11","scope":"insider","n_lines":2},{"id":4027579,"accession":"0000950170-25-069132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-069132","line_url":"/filing/0000950170-25-069132#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (See \"Remarks\")","role_mark":"O","role_mark_label":"Officer (See \"Remarks\")","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See \"Remarks\"","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":337915.0,"shares_display":"337,915","price_per_share":18.0439,"price_display":"18.04","price_state":"stated","total_value":6097304.4685,"total_display":"6,097,304.47","total_whole":"6,097,304","shares_owned_after":150996.0,"shares_owned_after_display":"150,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-08","filed_date":"2025-05-12","scope":"insider"},{"id":4416096,"accession":"0000950170-25-021151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-021151","line_url":"/filing/0000950170-25-021151#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (See \"Remarks\")","role_mark":"O","role_mark_label":"Officer (See \"Remarks\")","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See \"Remarks\"","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177626.0,"shares_display":"177,626","price_per_share":16.2508,"price_display":"16.25","price_state":"stated","total_value":2886564.6008,"total_display":"2,886,564.60","total_whole":"2,886,565","shares_owned_after":204964.0,"shares_owned_after_display":"204,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider"},{"id":2675023,"accession":"0000950170-24-027959","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-027959","line_url":"/filing/0000950170-24-027959#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (EVP, International Markets)","role_mark":"O","role_mark_label":"Officer (EVP, International Markets)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, International Markets","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":13.5209,"price_display":"13.52","price_state":"stated","total_value":1352090.0,"total_display":"1,352,090.00","total_whole":"1,352,090","shares_owned_after":382590.0,"shares_owned_after_display":"382,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-07","scope":"insider"},{"id":4823844,"accession":"0001209191-21-021298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-021298","line_url":"/filing/0001209191-21-021298#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (See \"Remarks\" below)","role_mark":"O","role_mark_label":"Officer (See \"Remarks\" below)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See \"Remarks\" below","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127244.0,"shares_display":"127,244","price_per_share":11.2195,"price_display":"11.22","price_state":"stated","total_value":1427614.058,"total_display":"1,427,614.06","total_whole":"1,427,614","shares_owned_after":20598.0,"shares_owned_after_display":"20,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-16","filed_date":"2021-03-17","scope":"insider"},{"id":3276541,"accession":"0001209191-20-009880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-009880","line_url":"/filing/0001209191-20-009880#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (See \"Remarks\" below)","role_mark":"O","role_mark_label":"Officer (See \"Remarks\" below)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See \"Remarks\" below","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72130.5421,"shares_display":"72,130.54","price_per_share":13.0286,"price_display":"13.03","price_state":"stated","total_value":939759.98080406,"total_display":"939,759.98","total_whole":"939,760","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-18","scope":"insider"},{"id":6132230,"accession":"0001209191-18-011097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-011097","line_url":"/filing/0001209191-18-011097#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (EVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (EVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Human Resources","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":20.52,"price_display":"20.52","price_state":"stated","total_value":61560.0,"total_display":"61,560.00","total_whole":"61,560","shares_owned_after":41516.5421,"shares_owned_after_display":"41,516.54","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-20","scope":"insider"},{"id":6132225,"accession":"0001209191-18-011097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-011097","line_url":"/filing/0001209191-18-011097#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001721442","owner_name":"Sabag Mark","owner_display_name":"Sabag Mark","owner_url":"/insider/0001721442","role":"Officer (EVP, Global Human Resources)","role_mark":"O","role_mark_label":"Officer (EVP, Global Human Resources)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Global Human Resources","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":18.45,"price_display":"18.45","price_state":"stated","total_value":37822.5,"total_display":"37,822.50","total_whole":"37,823","shares_owned_after":44516.5421,"shares_owned_after_display":"44,516.54","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-14","filed_date":"2018-02-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (See \"Remarks\")","n_filings":9,"first_seen":"2018-02-20","last_seen":"2026-05-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001721442","retrieved_at":"2026-08-27T23:31:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}